This report contains market size and forecasts of PARP Inhibitor Biomarkers Service in Global, including the following market information:
Global PARP Inhibitor Biomarkers Service Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global PARP Inhibitor Biomarkers Service market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
BRCA 1 & 2 Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PARP Inhibitor Biomarkers Service include Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc. and BPS Bioscience, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PARP Inhibitor Biomarkers Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PARP Inhibitor Biomarkers Service Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global PARP Inhibitor Biomarkers Service Market Segment Percentages, by Type, 2021 (%)
BRCA 1 & 2 Testing
HRD Testing
HRR Testing
Others
Global PARP Inhibitor Biomarkers Service Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global PARP Inhibitor Biomarkers Service Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global PARP Inhibitor Biomarkers Service Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global PARP Inhibitor Biomarkers Service Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PARP Inhibitor Biomarkers Service revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies PARP Inhibitor Biomarkers Service revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Myriad Genetics, Inc.
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories, Inc.
BPS Bioscience, Inc.